• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Nexalin Technology, Inc. - Common Stock (NQ:NXL)

    7.100 -0.130 (-1.80%)
    Streaming Delayed Price Updated: 9:30 AM EDT, Sep 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 852
    Open 7.100
    Bid (Size) 6.100 (100)
    Ask (Size) 7.150 (200)
    Prev. Close 7.230
    Today's Range 7.100 - 7.100
    52wk Range 6.250 - 60.00
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    These stocks are moving in today's session ↗
    Via Chartmill
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill

    Performance

    YTD
    -59.4%
    -59.4%
    1 Month
    -35.1%
    -35.1%
    3 Month
    -58.9%
    -58.9%
    6 Month
    -47.4%
    -47.4%
    1 Year
    -74.9%
    -74.9%

    More News

    Read More
    News headline image
    Nexalin Technology Announces Reverse Stock Split
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    Which stocks are moving before the opening bell on Tuesday? ↗
    Via Chartmill
    Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
    Via Chartmill
    News headline image
    Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia and Quality of Life
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Quality of Life as Company Advances Brazilian Sales Plan.
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    Discover the top movers in Friday's pre-market session. ↗
    Via Chartmill
    News headline image
    Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Veterans Affairs for Traumatic Brain Injury
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    RedChip's Biotech Investor Conference Replays Now Available
    Via ACCESS Newswire
    News headline image
    Nexalin Advances FDA Alzheimer’s Strategy Following Landmark Leadership Meetings in the U.S. and China
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Join Nexalin’s Exclusive Live Investor Webinar and Q&A Session on April 21
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Announces Peer-Reviewed Study Showing the Company’s DIFS™ Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference
    Via ACCESS Newswire
    News headline image
    Nexalin Announces Pivotal HALO™ Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Participates in and Commends Recent Congressional Momentum Supporting Deep Brain Neurostimulation Research for Veterans and Neurological Disorders
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Technology and First Phosphate Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESS Newswire
    Unusual volume stocks in Friday's session ↗
    Via Chartmill
    News headline image
    Nexalin Launches NeuroCare®, an AI-Driven Virtual Clinic Designed to Transform Access for Patients with Alzheimer’s, Mood Disorders, TBI & PTSD Care
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    Discover the top movers in Thursday's pre-market session. ↗
    Via Chartmill

    Frequently Asked Questions

    Is Nexalin Technology, Inc. - Common Stock publicly traded?
    Yes, Nexalin Technology, Inc. - Common Stock is publicly traded.
    What exchange does Nexalin Technology, Inc. - Common Stock trade on?
    Nexalin Technology, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Nexalin Technology, Inc. - Common Stock?
    The ticker symbol for Nexalin Technology, Inc. - Common Stock is NXL on the Nasdaq Stock Market
    What is the current price of Nexalin Technology, Inc. - Common Stock?
    The current price of Nexalin Technology, Inc. - Common Stock is 7.100
    When was Nexalin Technology, Inc. - Common Stock last traded?
    The last trade of Nexalin Technology, Inc. - Common Stock was at 09/01/26 09:30 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.